Coherus Oncology, Inc. - Common Stock, $0.0001 par value per share (CHRS)

CUSIP: 19249H103

Q3 2024 13F Holders as of 30 Sep 2024

Type / Class
Equity / Common Stock, $0.0001 par value per share
Shares outstanding
153,624,096
Total 13F shares
76,943,748
Share change
-5,673,419
Total reported value
$79,924,458
Put/Call ratio
123%
Price per share
$1.04
Number of holders
127
Value change
-$11,982,900
Number of buys
54
Number of sells
53

Security key

19249H103

Report period

Q3 2024

Institutions

127

Top holders

10

Top shareholders of CHRS - Coherus Oncology, Inc. - Common Stock, $0.0001 par value per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
BlackRock Finance, Inc.
13F
Company
7.7%
11,752,500
$20,331,825 30 Jun 2024
13F
VANGUARD GROUP INC
13F
Company
6.9%
10,602,389
$18,342,133 30 Jun 2024
13F
Rubric Capital Management LP
13F
Company
6.8%
10,400,000
$17,992,000 30 Jun 2024
13F
Temasek Holdings (Private) Ltd
13F
Company
3.8%
5,818,802
$10,066,527 30 Jun 2024
13F
Kohlberg Kravis Roberts & Co. L.P.
13F
Company
2%
3,036,076
$5,252,413 30 Jun 2024
13F
CITADEL ADVISORS LLC
13F
Company
1.9%
2,843,448
$4,919,165 30 Jun 2024
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
1.6%
2,382,231
$4,121,677 30 Jun 2024
13F
BARCLAYS PLC
13F
Company
1.4%
2,190,521
$3,789,602 30 Jun 2024
13F
GOLDMAN SACHS GROUP INC
13F
Company
1.4%
2,160,031
$3,736,853 30 Jun 2024
13F
STATE STREET CORP
13F
Company
1.3%
2,012,753
$3,482,063 30 Jun 2024
13F
C WorldWide Group Holding A/S
13F
Company
1.3%
1,928,464
$3,336,000 30 Jun 2024
13F
MORGAN STANLEY
13F
Company
1%
1,556,850
$2,693,352 30 Jun 2024
13F
DISCIPLINED GROWTH INVESTORS INC /MN
13F
Company
0.82%
1,257,089
$2,174,764 30 Jun 2024
13F
CM Management, LLC
13F
Company
0.72%
1,100,000
$1,903,000 30 Jun 2024
13F
TANG CAPITAL MANAGEMENT LLC
13F
Company
0.68%
1,050,000
$1,816,500 30 Jun 2024
13F
Tejara Capital Ltd
13F
Company
0.67%
1,030,386
$1,782,568 30 Jun 2024
13F
PEREGRINE CAPITAL MANAGEMENT LLC
13F
Company
0.66%
1,012,635
$1,751,859 30 Jun 2024
13F
JACOBS LEVY EQUITY MANAGEMENT, INC
13F
Company
0.65%
1,001,057
$1,731,829 30 Jun 2024
13F
AlphaCentric Advisors LLC
13F
Company
0.65%
1,000,000
$1,730,000 30 Jun 2024
13F
NORTHERN TRUST CORP
13F
Company
0.59%
913,746
$1,580,780 30 Jun 2024
13F
MACQUARIE GROUP LTD
13F
Company
0.59%
899,999
$1,557,000 30 Jun 2024
13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC
13F
Company
0.55%
848,110
$1,467,230 30 Jun 2024
13F
BIT Capital GmbH
13F
Company
0.55%
838,947
$1,451,378 30 Jun 2024
13F
TWO SIGMA INVESTMENTS, LP
13F
Company
0.54%
834,241
$1,443,237 30 Jun 2024
13F
Hudson Bay Capital Management LP
13F
Company
0.51%
785,000
$1,358,050 30 Jun 2024
13F
Clearline Capital LP
13F
Company
0.51%
784,449
$1,357,097 30 Jun 2024
13F
AQR CAPITAL MANAGEMENT LLC
13F
Company
0.47%
719,999
$1,245,598 30 Jun 2024
13F
Brandywine Global Investment Management, LLC
13F
Company
0.46%
699,645
$1,210,386 30 Jun 2024
13F
LAZARD ASSET MANAGEMENT LLC
13F
Company
0.41%
630,747
$1,091,000 30 Jun 2024
13F
MILLENNIUM MANAGEMENT LLC
13F
Company
0.4%
616,028
$1,065,728 30 Jun 2024
13F
NORGES BANK
13F
Company
0.32%
491,500
$850,295 30 Jun 2024
13F
CITIGROUP INC
13F
Company
0.3%
464,455
$803,507 30 Jun 2024
13F
MARSHALL WACE, LLP
13F
Company
0.27%
420,326
$727,163 30 Jun 2024
13F
BNP PARIBAS FINANCIAL MARKETS
13F
Company
0.27%
411,100
$711,203 30 Jun 2024
13F
RENAISSANCE TECHNOLOGIES LLC
13F
Company
0.26%
394,828
$683,052 30 Jun 2024
13F
Bank of New York Mellon Corp
13F
Company
0.25%
389,225
$673,359 30 Jun 2024
13F
WELLINGTON MANAGEMENT GROUP LLP
13F
Company
0.24%
369,702
$639,585 30 Jun 2024
13F
SEI INVESTMENTS CO
13F
Company
0.23%
355,392
$614,828 30 Jun 2024
13F
Woodline Partners LP
13F
Company
0.21%
322,680
$558,236 30 Jun 2024
13F
Bridge City Capital, LLC
13F
Company
0.21%
316,009
$546,696 30 Jun 2024
13F
BANK OF AMERICA CORP /DE/
13F
Company
0.18%
275,095
$475,914 30 Jun 2024
13F
XTX Topco Ltd
13F
Company
0.18%
271,433
$469,579 30 Jun 2024
13F
Birchview Capital, LP
13F
Company
0.18%
270,000
$467,100 30 Jun 2024
13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP
13F
Company
0.16%
248,681
$430,218 30 Jun 2024
13F
BRIDGEWAY CAPITAL MANAGEMENT, LLC
13F
Company
0.16%
243,000
$420,390 30 Jun 2024
13F
Tyche Wealth Partners LLC
13F
Company
0.14%
215,902
$373,510 30 Jun 2024
13F
TWO SIGMA ADVISERS, LP
13F
Company
0.14%
211,600
$366,068 30 Jun 2024
13F
LOS ANGELES CAPITAL MANAGEMENT LLC
13F
Company
0.14%
209,460
$362,366 30 Jun 2024
13F
JANE STREET GROUP, LLC
13F
Company
0.14%
208,473
$360,658 30 Jun 2024
13F
Jefferies Financial Group Inc.
13F
Company
0.13%
196,625
$340,161 30 Jun 2024
13F

Institutional Holders of Coherus Oncology, Inc. - Common Stock, $0.0001 par value per share (CHRS) as of Q3 2024

As of 30 Sep 2024, Coherus Oncology, Inc. - Common Stock, $0.0001 par value per share (CHRS) was held by 127 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 76,943,748 shares. The largest 10 holders included BlackRock, Inc., VANGUARD GROUP INC, Rubric Capital Management LP, Kohlberg Kravis Roberts & Co. L.P., CITADEL ADVISORS LLC, GEODE CAPITAL MANAGEMENT, LLC, BARCLAYS PLC, TANG CAPITAL MANAGEMENT LLC, GOLDMAN SACHS GROUP INC, and STATE STREET CORP. This page lists 127 institutional shareholders reporting positions in this security for the Q3 2024 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q3 2024 vs Q2 2024 Across Filers

Q2 2024 holders
132
Q3 2024 holders
127
Holder diff
-5
Investor Q2 2024 Shares Q3 2024 Shares Share Diff Share Chg % Q2 2024 Value $ Q3 2024 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .